The latest report by IMARC Group, titled "Digital Patient Monitoring Devices Market Report by Monitoring Type (Wireless Sensor Technology, mHealth, Telehealth, Wearable Devices, Remote Patient Monitoring), Product (Diagnostic Monitoring Devices, Therapeutic Monitoring Devices), End User (Hospitals, Home Settings, Ambulatory Surgical Centers (ASC)), and Region 2025-2033," finds that the global digital patient monitoring devices market size reached USD 154.1 Billion in 2024. Digital patient monitoring devices are electronic instruments used to monitor the patient's vital parameters, such as temperature, pulse rate, heart rate, and blood oxygen saturation levels (SPO2). They assist in delaying and preventing complications caused by the disease, reducing workload and errors, improving communication, increasing patient engagement and control, and enhancing safety. As a result, digital patient monitoring devices are extensively used in hospitals, clinics, ambulatory surgical centers (ASC), and home care settings.
Global Digital Patient Monitoring Devices Market Trends:
The market is primarily driven by the expanding healthcare industry. In addition, the growing prevalence of chronic diseases, such as asthma, blood pressure, hypertension, and diabetes, represents another major growth-inducing factor. Besides this, various manufacturers are introducing smart digital patient monitoring devices to analyze common physiological parameters. This, coupled with the escalating demand for sensor-based wearable monitoring devices, such as glucose monitors that help track blood sugar levels in real time, is positively influencing the market growth. Moreover, the rising geriatric population, the increasing expenditure capacity of consumers, and widespread product adoption in home care settings due to the sudden outbreak of coronavirus disease are some of the other factors propelling the market growth. Looking forward, IMARC Group expects the market value to reach USD 773.7 Billion by 2033, exhibiting a CAGR of 19.6% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Monitoring Type, Product, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, AT&T Inc., Athenahealth Inc., F. Hoffmann-La Roche AG, General Electric Company, Hill-Rom Holdings Inc. (Baxter International Inc.), Johnson & Johnson, Koninklijke Philips N.V, Medtronic plc, Nihon Kohden Corporation, OMRON Corporation and ResMed. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800